Business
Axcelis Announces Financial Results For Third Quarter 2021
The Company Reports Record Implant Systems Revenue and Backlog BEVERLY, Mass., Nov. 3, 2021 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a
About this update from Axcelis Technologies, Inc.
[{"type":"text","content":"The Company Reports Record Implant Systems Revenue and Backlog\n\n\nBEVERLY, Mass., Nov. 3, 2021 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced financial results for the third quarter ended September 30, 2021. \n\n \n \n \n \n \n \n\n \nAxcelis announced financial results for Q3 2021. The Company reports record Implant Systems Revenue and Backlog.Highlights for the third quarter are as follows:\nThe Company reported third quarter revenue of $176.7 million, compared to $147.3 million for the second quarter of 2021. This includes quarterly system revenues of $126.2 million dollars, an implant systems record, compared to $100.1 million in the second quarter. Operating profit for the quarter was $36.4 million, compared to $24 million for the second quarter. Net income for the quarter was $27.5 million, or $0.81 per diluted share, compared to net income of $18.9 million, or $0.55 per diluted share for the second quarter. Gross margin for the quarter was 43.3%, compared to 43.5% in the second quarter. Shipped full family of Purion SiC Power Series™ implanters to leading power device chipmakers located in Asia and Europe. Shipped multiple Purion™ high current and high energy implanters to a leading memory device manufacturer located in Asia.President and CEO Mary Puma commented, \"Axcelis delivered very strong third quarter financial performance driven by record implant systems revenue and solid gross margins. The mature and specialty markets, especially the implant-intensive power device segment, are generating significant market expansion. Axcelis is capitalizing on the strength of these segments with market leading Purion product extensions specifically designed to meet these customers' requirements. The Company is well positioned for long-term, sustainable growth.\"\nBusiness OutlookFor the fourth quarter ending December 31, 2021, Axcelis expects revenues to be approximately $190 million. Gross margin in the fourth quarter is expected to be approximately 41.5%. Fourth quarter operating profit is forecasted to be approximately $37 million with earnings per diluted share of approximately $0.84. The Company also expects to exceed $640 million in revenue for the full year 2021. \nThird Quarter 2021 Conference CallThe Co...